Press ReleaseGlobal Chimeric Antigen Receptor (Car) T-Cell Therapy Industry Anticipates Robust Growth at 6.9%, Enroot to US$6.82 Billion by 2033 | FMI Feb 9, 2024 Nikhil KaitwadeComment on Global Chimeric Antigen Receptor (Car) T-Cell Therapy Industry Anticipates Robust Growth at 6.9%, Enroot to US$6.82 Billion by 2033 | FMI The Global Chimeric Antigen Receptor (Car) T-Cell Therapy Industry is on an upward trajectory, showcasing